Pdg Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 11-12-2024
- Paid Up Capital ₹ 1.00 M
as on 11-12-2024
- Company Age 19 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 15.53 Cr
as on 11-12-2024
- Revenue %
(FY 2022)
- Profit 5.51%
(FY 2022)
- Ebitda -3.92%
(FY 2022)
- Net Worth -3.62%
(FY 2022)
- Total Assets 15.92%
(FY 2022)
About Pdg Pharmachem
The Corporate was formerly known as P.V. Steel And Rolling Mills Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹15.53 Cr.
Amit Goel and Vijay Goel serve as directors at the Company.
- CIN/LLPIN
U27310DL2005PTC132747
- Company No.
132747
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Feb 2005
- Date of AGM
31 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- LocationNa, Delhi
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pdg Pharmachem?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Goel  | Director | 30-Nov-2012 | Current |
| Vijay Goel | Director | 07-Feb-2005 | Current |
Financial Performance of Pdg Pharmachem.
Pdg Pharmachem Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 5.51% increase in profit. The company's net worth dipped by a decrease of 3.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pdg Pharmachem?
In 2022, Pdg Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Black Gold Enterprises Private LimitedActive 13 years 5 months
Amit Goel and Vijay Goel are mutual person
- Dykes & Dunes Enterprises Private LimitedActive 13 years 5 months
Amit Goel and Vijay Goel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 May 2017 | ₹8.00 Cr | Open |
Indiabulls Housing Finance Limited Creation Date: 04 Nov 2014 | ₹7.53 Cr | Open |
How Many Employees Work at Pdg Pharmachem?
Unlock and access historical data on people associated with Pdg Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pdg Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pdg Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
